Nicole Forster

797 total citations
20 papers, 641 citations indexed

About

Nicole Forster is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nicole Forster has authored 20 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Surgery. Recurrent topics in Nicole Forster's work include Fibroblast Growth Factor Research (4 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Nicole Forster is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Nicole Forster collaborates with scholars based in United States, Switzerland and Germany. Nicole Forster's co-authors include Leif W. Ellisen, Matthew R. Ramsey, Benjamin Ory, Lei He, Annette Adler, H. Ulrich Göringer, Matthias Homann, S. Michael Rothenberg, Srinivas Vinod Saladi and Frank E. Jones and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Nicole Forster

19 papers receiving 635 citations

Peers

Countries citing papers authored by Nicole Forster

Since Specialization

Citations

This map shows the geographic impact of Nicole Forster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Forster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Forster more than expected).

Fields of papers citing papers by Nicole Forster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Forster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Forster. The network helps show where Nicole Forster may publish in the future.

Co-authorship network of co-authors of Nicole Forster

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Forster. A scholar is included among the top collaborators of Nicole Forster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Forster. Nicole Forster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination 2024 ·Frontiers in Oncology ·(unknown), Nicole Forster, Felix Bachmann, (unknown), Paul M.J. McSheehy, (unknown), (unknown), Anna C. Groner, Mila Roceri, (unknown), (unknown), Nicole Willemsen‐Seegers, Jos de Man, (unknown), (unknown), Guido J.R. Zaman, Rogier C. Buijsman, Laurenz Kellenberger, Heidi A. Lane	1
2	The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivo 2022 ·Anti-Cancer Drugs ·Paul M.J. McSheehy, Nicole Forster, (unknown), Felix Bachmann, Mila Roceri, (unknown), Jochen Spickermann, Laurenz Kellenberger, Heidi A. Lane	7
3	42P BAL0891: A novel, small molecule, dual TTK/PLK1 mitotic checkpoint inhibitor (MCI) with potent single agent activity 2022 ·Annals of Oncology ·Heidi A. Lane, (unknown), Nicole Forster, (unknown), Felix Bachmann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mila Roceri, (unknown), Paul M.J. McSheehy, Laurenz Kellenberger	0
4	Abstract 5645: BAL0891: A novel dual TTK/PLK1 mitotic checkpoint inhibitor (MCI) that drives aberrant tumor cell division resulting in potent anti-cancer activity 2022 ·Cancer Research ·Heidi A. Lane, Felix Bachmann, (unknown), Paul M.J. McSheehy, (unknown), Nicole Forster, (unknown), (unknown), Jos de Man, Wilhelmina E. van Riel, (unknown), Rogier C. Buijsman, Laurenz Kellenberger	1
5	Derazantinib: an investigational drug for the treatment of cholangiocarcinoma 2021 ·Expert Opinion on Investigational Drugs ·Stephan Braun, Paul M.J. McSheehy, (unknown), (unknown), Nicole Forster, Felix Bachmann, Mahmoud El‐Shemerly, (unknown), (unknown), (unknown), Ping Zhou, Heidi A. Lane, Laurenz Kellenberger, Marc Engelhardt	15
6	The FGFR-inhibitor derazantinib (DZB) is active in PDX-models of GI-cancer with specific aberrations in FGFR. 2020 ·Journal of Clinical Oncology ·Paul M.J. McSheehy, Felix Bachmann, Nicole Forster, (unknown), Mila Roceri, Laurenz Kellenberger, Heidi A. Lane	2
7	Abstract LB-C12: Derazantinib (DZB): A dual FGFR/CSF1R-inhibitor active in PDX-models of urothelial cancer 2019 ·Molecular Cancer Therapeutics ·Paul M.J. McSheehy, Felix Bachmann, Nicole Forster, (unknown), (unknown), Mila Roceri, Stefan Reinelt, Laurenz Kellenberger, Paul R. Walker, Heidi A. Lane	5
8	Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1 2014 ·Developmental Cell ·Nicole Forster, Srinivas Vinod Saladi, (unknown), (unknown), Frank E. Jones, Zhe Li, Leif W. Ellisen	89
9	OTX2 mutations cause autosomal dominant pattern dystrophy of the retinal pigment epithelium 2014 ·Journal of Medical Genetics ·Ajoy Vincent, Nicole Forster, Jason T. Maynes, Tara Paton, Gail Billingsley, Nicole M. Roslin, Arfan Ali, Joanne Sutherland, Tom Wright, Carol A. Westall, Andrew D. Paterson, Christian R. Marshall, Elise Héon	31
10	A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma 2014 ·Journal of Clinical Investigation ·Benjamin Ory, Matthew R. Ramsey, Catherine Wilson, Douangsone D. Vadysirisack, Nicole Forster, James W. Rocco, S. Michael Rothenberg, Leif W. Ellisen	2
11	Abstract LB-212: Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. 2013 ·Cancer Research ·Lei He, Kristine Torres‐Lockhart, Nicole Forster, Saranya Ramakrishnan, Patricia Greninger, Mathew J. Garnett, Ultan McDermott, S. Michael Rothenberg, Cyril H. Benes, Leif W. Ellisen	1
12	Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma 2012 ·Cancer Discovery ·Lei He, Kristine Torres‐Lockhart, Nicole Forster, Saranya Ramakrishnan, Patricia Greninger, Mathew J. Garnett, Ultan McDermott, S. Michael Rothenberg, Cyril H. Benes, Leif W. Ellisen	54
13	Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma 2011 ·Cancer Research ·Matthew R. Ramsey, Lei He, Nicole Forster, Benjamin Ory, Leif W. Ellisen	89
14	A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma 2011 ·Journal of Clinical Investigation ·Benjamin Ory, Matthew R. Ramsey, Catherine Wilson, Douangsone D. Vadysirisack, Nicole Forster, James W. Rocco, S. Michael Rothenberg, Leif W. Ellisen	63
15	The Integrin αvβ3-5 Ligand MFG-E8 Is a p63/p73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers 2010 ·Cancer Research ·Chuanwei Yang, Tetsu Hayashida, Nicole Forster, (unknown), Dejun Shen, Shyamala Maheswaran, Li Chen, Karen S. Anderson, Leif W. Ellisen, Dennis C. Sgroi, Emmett V. Schmidt	58
16	Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation 2008 ·The EMBO Journal ·Axel Weber, (unknown), David J. Elzi, Nicole Forster, (unknown), (unknown), Daisuke Yamada, Pierre‐Antoine Defossez, Jeffrey J. Delrow, Robert N. Eisenman, Holger Christiansen, Martin Eilers	82
17	Post-SELEX Chemical Optimization of a Trypanosome-Specific RNA Aptamer 2008 ·Combinatorial Chemistry & High Throughput Screening ·H. Ulrich Göringer, Annette Adler, Nicole Forster, Matthias Homann	62
18	p300 Protein Acetyltransferase Activity Suppresses Systemic Lupus Erythematosus-Like Autoimmune Disease in Mice 2007 ·The Journal of Immunology ·Nicole Forster, (unknown), Jadwiga Jabłońska, Siegfried Weiß, Hans‐Peter Elsässer, W. Lutz	33
19	Effect of Sample Storage on the Assay of Lipoprotein(a) by Commercially Available Radial Immunodiffusion and Enzyme-Linked Immunosorbent Assay Kits 1992 ·Clinical Chemistry ·Wendy Y. Craig, (unknown), Nicole Forster, Louis M. Neveux, N J Wald, Thomas B. Ledue	43
20	An improved method for determining high molecular weights by protein immunoblotting: application to apolipoprotein(a) phenotyping. 1991 ·PubMed ·Wendy Y. Craig, Nicole Forster, Thomas B. Ledue, Margaret Johnson, Louis M. Neveux, Robert F. Ritchie	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact